TNF Pharmaceuticals Files 8-K/A Amendment
Ticker: QCLS · Form: 8-K/A · Filed: Sep 5, 2025 · CIK: 1321834
| Field | Detail |
|---|---|
| Company | Tnf Pharmaceuticals, Inc. (QCLS) |
| Form Type | 8-K/A |
| Filed Date | Sep 5, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, financial-statements, exhibits
TL;DR
TNF Pharma filed an amendment to its 8-K, updating financial statement info. Nothing major changed, just housekeeping.
AI Summary
TNF Pharmaceuticals, Inc. filed an 8-K/A on September 5, 2025, to amend a previous filing related to financial statements and exhibits as of September 2, 2025. The company, formerly known as MyMD Pharmaceuticals, Inc., is incorporated in Delaware and headquartered in New York.
Why It Matters
This filing is an amendment to a previous report, indicating a correction or addition to previously disclosed information regarding financial statements and exhibits.
Risk Assessment
Risk Level: low — This is a routine amendment to a previous filing, not indicating new material events or financial distress.
Key Players & Entities
- TNF Pharmaceuticals, Inc. (company) — Registrant
- September 2, 2025 (date) — Earliest event reported
- September 5, 2025 (date) — Filing date
- MyMD Pharmaceuticals, Inc. (company) — Former company name
- Akers Biosciences, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- New York (location) — Business address city
FAQ
What is the purpose of this 8-K/A filing?
This 8-K/A filing is an amendment to a previous report, specifically to update information regarding financial statements and exhibits as of September 2, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on September 2, 2025.
What is the filing date of this 8-K/A?
This 8-K/A was filed on September 5, 2025.
What were TNF Pharmaceuticals, Inc.'s former company names?
TNF Pharmaceuticals, Inc. was formerly known as MyMD Pharmaceuticals, Inc. and Akers Biosciences, Inc.
In which state is TNF Pharmaceuticals, Inc. incorporated?
TNF Pharmaceuticals, Inc. is incorporated in Delaware.
Filing Stats: 881 words · 4 min read · ~3 pages · Grade level 13.1 · Accepted 2025-09-05 17:30:47
Key Financial Figures
- $0.001 — ch registered Common stock, par value $0.001 per share TNFA The Nasdaq Capital M
Filing Documents
- form8-ka.htm (8-K/A) — 45KB
- ex10-1.htm (EX-10.1) — 241KB
- ex10-2.htm (EX-10.2) — 47KB
- ex10-3.htm (EX-10.3) — 141KB
- ex10-4.htm (EX-10.4) — 298KB
- 0001641172-25-026762.txt ( ) — 1065KB
- tnfa-20250902.xsd (EX-101.SCH) — 3KB
- tnfa-20250902_lab.xml (EX-101.LAB) — 33KB
- tnfa-20250902_pre.xml (EX-101.PRE) — 22KB
- form8-ka_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TNF PHARMACEUTICALS, INC. Date: September 5, 2025 By: /s/ Joshua Silverman Joshua Silverman Executive Chairman